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SARS-CoV and emergent coronaviruses: viral determinants of
interspecies transmission
Meagan Bolles1, Eric Donaldson2 and Ralph Baric1,2Most new emerging viruses are derived from strains circulating
in zoonotic reservoirs. Coronaviruses, which had an
established potential for cross-species transmission within
domesticated animals, suddenly became relevant with the
unexpected emergence of the highly pathogenic human SARS-
CoV strain from zoonotic reservoirs in 2002. SARS-CoV
infected approximately 8000 people worldwide before public
health measures halted the epidemic. Supported by robust
time-ordered sequence variation, structural biology, well-
characterized patient pools, and biological data, the
emergence of SARS-CoV represents one of the best-studied
natural models of viral disease emergence from zoonotic
sources. This review article summarizes previous and more
recent advances into the molecular and structural
characteristics, with particular emphasis on host–receptor
interactions, that drove this remarkable virus disease outbreak
in human populations.
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Introduction
Coronaviruses have an established potential for cross-
species transmission that became broadly recognized with
the emergence of a novel human coronavirus, Severe
Acute Respiratory Syndrome Coronavirus (SARS-CoV),
in 2002. SARS was first identified as an atypical pneu-
monia in isolated patients in Guangdong Province, China.
The disease reached epidemic proportions following key
super spreader events that were associated with a novel
respiratory virus introduction into a globalized com-
munity. SARS-CoV caused about 8000 infections and
800 deaths worldwide by July 2003, by which time
aggressive public health intervention strategies contained
the epidemic absent any effective therapeutics [1]. Thedecimating lethality of SARS-CoV emergence was borne
largely by the elderly, in whom mortality rates
approached 50% or more. A subsequent explosion of
coronavirus research identified SARS-CoV in several
small carnivores (palm civets and raccoon dogs) of the
Chinese wetmarkets and SARS-like CoV in the predicted
reservoir host, horseshoe bats (genus Rhinolophus). The
vastly expanded CoV phylogeny includes two novel
human coronaviruses (NL63 and HKU1) and ultimately
tripled the number of full-length genome sequences
available in GenBank. SARS-CoV was shown to use a
novel host receptor, Angiotensin Converting Enzyme 2
(ACE2), for docking and entry and the viral attachment
protein, Spike, was extensively characterized both as a
determinant of host specificity and as a therapeutic target.
Themore recent studies of coronaviruses have progressed
to increased surveillance and characterization of numer-
ous new coronaviruses circulating in bats, bids, and other
species, integrated bioinformatics and microbiological
studies, and extensive evaluations of potential thera-
peutics [2].
Coronavirus phylogeny and mechanisms of
genome diversity
Following the SARS-CoV outbreak a surge in global
coronavirus genome sequencing efforts vastly expanded
our insight into the CoV phylogeny and resulted in the
definition of several subclassifications (Figure 1). The
greatest contribution of new strains was derived from the
newly discovered bat coronavirus (BtCoV), which may be
the source of most, if not all, mammalian CoVs identified
to date [3–9]. The high diversity of coronaviruses is
attributable to three viral traits [10]. The first character-
istic is the potentially high mutation rates associated with
RNA replication, generally estimated as 103 to 105.
Surprisingly, the estimated mutation rate for SARS-CoV
and other coronaviruses approached 2  106 [11–13]. In
contrast to other RNA viruses, recent data suggest that
coronaviruses encode an RNA proof-reading activity
associated with the 30–50 exonuclease activity encoded
within nsp14 [14]. It is not clear whether RNA proof-
reading fidelity is altered in changing environmental
settings or during virus replication under stress related
conditions, but such possibilities may allow for rapid virus
evolution in changing ecologic conditions [14]. Second,
recombination frequencies within the coronavirus family
have been calculated to be as high as 25% during mixed
infection, likely the result of discontinuous RNA tran-
scription and the presence of full length and subgenomic
negative strand RNAs that allow for frequent strand
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Spike phylogeny of representative CoVs and models of SARS-CoV
emergence. (a) The Spike peptide sequence of 40 representative CoVs
demonstrates that CoVs make up three distinct groups named alpha,
beta, and gamma. These names replaced the former group 1, 2, and 3
designation, respectively. Classical subgroup clusters are marked as
2a–2d for the beta CoVs and 1a and 1b for the alpha CoVs. The tree was
generated via Maximum Likelihood using the PhyML package. Major
branch labels represent bootstraps that were greater than 70. SCoV:
SARS-CoV; BtSCoV: bat SARS-like CoV; BtCoV, ZBCoV, and ARCoV:
bat CoVs; HCoV: human; FCoV and FIPV: feline CoVs; BCoV: bovine;
IBV: avian; PHEV, TGEV, PRV, PEDV: porcine CoVs; and MHV: murine
hepatitis virus. (b) Competing models of SARS-CoV emergence. Earlyswitching and recombination between viral genomes and
subgenomic replication complexes [15,16]. The role of
discontinuous transcription in recombination is supported
by the higher rate of recombination toward the 30 ends of
viral genomes and by targeted RNA recombination tech-
niques designed to genetically manipulate the 30 end of
the genome [17]. Although poorly studied, conservation
of transcription regulatory sequence (TRS) sites across
viral species may implicate these sequences as foci or hot
spots of recombination [17]. Thirdly, as the largest of the
RNA viruses at 27–31 kb, coronaviruses have both
increased opportunity for change and room for modifi-
cation, clearly evidenced by the presence of numerous
unique open reading frames and protein functions
encoded toward the 30 end of the genome [10]. These
genomic characteristics allow for rapid adaptation to novel
hosts, ecological niches, tissue tropism, and even gener-
ation of novel coronavirus species, as seen in the gener-
ation of FIPV type II strains from double recombination
events between FIPV type I and CCoV [10].
Multiple incidents of cross-species
transmission
Coronaviruses have a strong history of host shifting as
evidenced by phylogenetic incongruences in the family
tree [18]. In addition to SARS-CoV, two human corona-
viruses, HCoV-OC43 and HCoV-229E, are now also
recognized as having likely emerged from animal reser-
voirs. HCoV-OC43 and bovine coronavirus (BCoV), both
betacoronaviruses, have very high sequence similarity
suggesting a recent and common origin (Figure 1). Mol-
ecular clock analysis of the Spike glycoprotein of both
species estimates that HCoV-OC43 originated from a
BCoV ancestor around 1890 [19]. Similarly, HCoV-
229E likely emerged from a bat alphacoronavirus approxi-
mately 200 years ago [20]. In an example of reverse
zoonosis, porcine epidemic diarrhea virus emerged sud-
denly in the early 1980s, most likely originating from
HCoV-229E [20]. Additionally, a coronavirus isolated in
1988 from a child with acute diarrhea, HECV-4408, was
shown to be closely related to bovine coronavirus (BCoV),
indicating the continued introduction of zoonotic coro-
naviruses into human populations [21]. The origins of
HCoV-NL63 and HCoV-HKU1, the most recently dis-
covered human coronaviruses, remain under study. The
most recent example of zoonotic emergence of a human
coronavirus is the example of SARS-CoV, which had at
least two independent emergence events from zoonotic
reservoirs, recognized in 2002 and 2003 [22]. The most
recent phylogenetic data estimate the emergence of
SARS-CoV some seven years earlier, consistent withdata suggested that SARS-CoV initially jumped from the zoonotic
reservoir, bats, to palm civets, followed by a second jump from civets to
humans (blue arrow). More recent phylogenetic and receptor analysis
studies suggest a direct emergence from bats to humans, with
subsequent cross-transmission between humans and civets (red arrow).
the identification of low sero-positive cases from archived 
serum samples in 2001 in China [23].
SARS-related CoVs in bats
Following its emergence in 2003, SARS was quickly 
identified as a zoonotic virus, and the identification of 
the wet markets as a potential source may have assisted 
epidemiological control of the disease [24]. While palm 
civets, raccoon dogs, and horseshoe bats (Rhinolophus 
genus) have all been identified as hosts of SARS-like 
CoVs, it is suggested that only the horseshoe bats are 
likely reservoir hosts. Bats are widely distributed, highly 
diverse, and extremely mobile mammals with an estab-
lished role as hosts of emergent RNA viruses. Corona-
viruses occupy an exceptionally wide distribution in bats; 
recent surveillance studies have extended our recognition 
of this range to Africa, Europe, South America, and North 
America [4,9,25–27]. The genetic variation encoded 
within many recently discovered coronaviruses hosted 
by bats is far greater than the diversity noted between 
many human coronaviruses, despite a proportionally small 
sampling of the 1200 bat species, leading some 
researchers to speculate that all mammalian coronaviruses 
are derived from bat reservoir strains [4,28]. The exten-
sive sequence diversity provides considerable opportu-
nity for the emergence of new animal and human 
coronaviruses, which would be sufficiently antigenically 
distinct as to not be influenced by preexisting exposure 
and memory immune responses to established human 
CoVs. For example, little antigenic cross reactivity exists 
between the S glycoproteins of more distantly related 
group 2b bat coronaviruses and the SARS-CoV [29]. From 
a historic context, the next emergent event is likely 
dependent only on ecological and epidemiological situ-
ations and time, as the viral potential is well established 
[30,31].
Repeated efforts have been made in recent years to 
identify the zoonotic reservoir and path of emergence 
for SARS-CoV, both by sampling zoonotic populations 
and by attempting to clarify SARS-CoV receptor usage in 
alternate hosts. A recent study attempting to address the 
paucity of bat SARS-related coronavirus sequences gath-
ered and analyzed SARS-related coronaviruses in Rhino-
lophus bats (SARSr-Rh-BatCoV) (Rp3) genomes from 
horseshoe bats in China [32]. Interestingly, several bats 
sampled were coinfected with HKU2, an alphacorona-
virus, providing direct evidence that individual bats can 
host divergent coronaviruses, even across groups. Further, 
tagging and clinical assessment of infected bats over a 
four-year period showed only minor weight loss associ-
ated with Rp3 infection, with viral clearance occurring 
between two weeks and four months. Analysis of the ten 
novel genomes gathered in this study combined with 
previously published sequences demonstrated evidence 
of frequent recombination between the strains. They also 
note a 26-bp deletion in ORF8 near, but not identical to,the 29-bp deletion seen in human SARS-CoV epidemic
strains, suggesting ORF8may undergo frequent deletions
[32].
ACE2 is the receptor for SARS-CoV, but following the
identification of several SARS-like CoVs (SL-CoVs) in
horseshoe bats (genus Rhinophus) the ACE2 molecule of
R. pearsonii proved incapable of serving a receptor for
SARS-CoV [3,33]. These and other initial studies
suggested that the ancestral SARS-CoV strain in bats
used an alternate receptor and that the emergence of
SARS-CoV was dependent upon either acquisition of an
ACE2 binding region or initial utilization of an alternative
human receptor [33]. However, while human ACE2 is
genetically conserved, the bat ACE2 sequences are
highly heterogeneous, with 78–84% amino acid identity
between families [34,35]. Despite this heterogeneity, the
residues that interface with the SARS Spike–receptor
binding domain (RBD) are more conserved [36]. A recent
study determined that a minimum three substitutions in
the ACE2 of R. pearsonii (RpACE2) allowed this protein
to serve as a receptor for SARS [37]. Looking more
broadly at the ACE2 molecules from seven bat species,
the ACE2 proteins fromMyotis daubentoni and Rhinolophus
sinicus are capable of supporting Spike-mediated pseu-
dovirus and SARS-CoV infection, though less efficiently
than human ACE2 [34]. Assessment of receptor usage by
early phase and civet isolate Spike proteins might better
inform our understanding of emergence pathways, deter-
mining if SL-CoV jumped directly from bat to human
hosts or whether civet or other intermediate hosts were
required as early intermediates before human adaptation.
Although original data suggested a bat to civet to human
origin, evidence supporting direct bat to human trans-
mission of SL-CoV emerged from recent phylogenetic
studies, in addition to the receptor studies mentioned
above (Figure 1b). Initially, a reanalysis of published
genome sequences developed phylogenies using out-
groups that were non-SARS-CoV sequences, designed
to test the monophyly of the SARS-CoV sequences
[38]. Under this assessment, bat isolates are ancestral
host to all SARS-CoVs, while civet and raccoon dog
sequences (small carnivores), as well as pig isolates cluster
within the human SARS-CoV sequences. The small
carnivore CoVs are consistently shown to be terminal
branches with human CoVs intermediate, with later
transmission of CoV between carnivores and humans
responsible for isolated cases such as GD03, a late phase
human isolate that phylogenetically clusters with civet
rather than human sequences [38]. This phylogeny there-
fore supports a direct bat to human transmission, with
subsequent and bidirectional transmissions between civet
cats, raccoon dogs, and humans.
A more recent study analyzed CoV sequences gathered
from 24 R. sinicus bats in geographically distant regions of
Figure 2
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Sequence changes over the SARS-CoV epidemic. Shown here are the most significant changes important for transition of SARS from civet to early,
middle and late phases of epidemic strains. Mutations indicative of lineages that were not likely to have contributed to the expansion to other phases
have been removed. All other positions in the genome are identical.China, characterizing two distinct genotypes, Rs672 and
Rs806 [39]. Interestingly, one sequence (Rs672) and the
previously published Rp3 are shown in amonophylymore
closely related to human-SCoV than to bat SARS-like
CoV strains, based on the strong similarity of Rs672
ORF1a/b region to human SARS sequences. This study
also provided further evidence of recombination between
Bat-SL-CoV, with a recombination breakpoint identified
immediately after the start codon of Spike, identical to
the recombination position in the Rp3 genome [39]. The
combination of highly diverse BtCoV species and diver-
gent ACE2molecules among bat hosts suggests direct bat
to human transmission may be feasible. Thus, the field is
left with two potentially competing models for the origins
of the SARS-CoV epidemic: first, transmission from bats
to an intermediate amplifying reservoir in small carni-
vores, with subsequent transmission to humans or second,
direct bat to human transmission followed by cross-trans-
mission between humans and civets and raccoon dogs
(Figure 1b). In both models civets and raccoon dogs serve
as key amplifying hosts for virus persistence and reintro-
duction into human populations.
Genesis of an epidemic
A chronological set of SARS-CoV sequence changes
spanning the SARS outbreak provided an unparalleled
opportunity to identify the genetic basis for zoonotic virus
cross-species transmission and human adaptation during
an expanding epidemic. Molecular changes noted at withthe end of the early phase and expansion into the middle
phase of the epidemic include A3047V, A3072V in the
replicase and D778Y and perhaps E1163K in the Spike
gene. Transition from the middle to late phase of the
epidemic included A2552V in ORF1a, E1389D in ORF1b,
D77G and T244I in the S gene, respectively (Figure 2)
[40]. It has been hypothesized that these alterations were
key to an expanding epidemic, yet empirical data to
support these claims and functional significance of these
alterations remain unavailable. For example, it is not clear
whether the ORF8 29 bp deletion is central for human
adaptation as suggested, or a genetic hitchhiker amplified
and maintained following a selective sweep mediated by
other beneficial mutations located elsewhere in the gen-
ome [3,40]. In addition to these changes, the SARS-CoV
Spike glycoprotein was under strong positive selection,
with 23 substitutions evolving during the expanding
phases of the epidemic [41]. Experimental evidence
suggests both adaptation to ACE2 and antibody selection
contributed to Spike changes [40,42].
Coronavirus cross-species transmission: role
of Spike–receptor interactions in viral entry
Coronavirus–receptor interactions are key determinants
regulating host range, cross-species transmission, and
tissue tropism. The various coronaviruses demonstrate
broad receptor and coreceptor usage, from proteases such
as aminopeptidase N for transmissible gastroenteritis
virus (TGEV), canine-CoV, feline infectious peritonitis
 virus (FIPV), and HCoV-229E, to cell adhesion molecules 
such as CEACAM1a for MHV, to sugars as coreceptors for 
some alpha, beta, and gammacoronaviruses [36,43,44]. 
This diverse receptor usage directly impacts host range 
and tissue tropism as demonstrated by the closely related 
PRCoV and TGEV. PRCoV lacks the sugar-binding 
region of TGEV, and consequently is limited to a respir-
atory rather than enteric tropism [45]. The recently 
crystallized structure of the group 2a coronavirus MHV 
complexed with its receptor, murine CEACAM1a, 
emphasizes again the broad diversity and flexibility of 
CoV Spike glycoproteins. The core structure of the MHV 
RBD is hypothesized to have been derived from a host 
sugar-binding protein (galectin) and subsequently modi-
fied to allow mCEACAM1a binding, thus enhancing 
MHV affinity for host cells [43]. Other coronaviruses 
encode a second putative viral attachment protein, the 
hemagglutinin esterase (HE), which was likely derived 
from influenza C strains by recombinatory mechanisms 
[46]. Coronaviruses selected in vitro to broaden host range 
oftentimes mutate to bind heparin sulfate for docking and 
entry [47]. It is notable that OC43 and BCoV have 
carbohydrate (sialic acid) binding capacities, as well as 
broader host ranges [48]. The capacity to bind carbo-
hydrates for docking and entry may provide an additional 
pathway for coronavirus host range expansion, cross-
species transmission, and disease emergence, and 
requires further study.
The key determinant of SARS coronavirus host speci-
ficity is the Spike glycoprotein, an envelope-anchored 
trimeric protein responsible for binding human ACE2 as 
the principle receptor for virus docking and entry. SARS-
CoV S glycoprotein also binds C-type lectins like DC-
Sign and/or L-Sign as a coreceptor, an interaction which 
is blocked by mannose binding lectin [49,50]. Impor-
tantly, SARS-CoV docking and entry is also highly de-
pendent upon transmembrane protease/serine subfamily 
member 2 (TMPRSS2) S and ACE2 cleavage, especially 
in airway and alveolar sites, and cathepsin L cleavage and 
subsequent S2 fusion activation [51–53]. Several studies 
in the past two  years have worked to clarify  the plasticity
of this protein, with particular emphasis on the RBD. 
The Spike glycoprotein underwent rapid evolution 
during the human epidemic [40], was the most signifi-
cantly variable protein across civet and human isolates 
[22], and shows evidence of positive selection during 
both interspecies and intraspecies transmission events 
[10,22,40,54]. The SARS Spike can recognize and use 
bat, civet, mouse, and raccoon dog ACE2 receptor mol-
ecules for docking and entry, indicating that SARS traf-
ficked along receptor ortholog networks to move 
between species [34,55,56]. As several alphacoronavir-
idae also use APN from different species, these data 
suggest a common theme in coronavirus host range 
switching: recognizing receptor orthologs from different 
species [36]. Additionally, the role of different orthologproteases for facilitating coronavirus S glycoprotein clea-
vage and entry processes remains undefined, and could
significantly contribute to the efficiency of virus cross-
species transmission processes.
SARS-CoV replicates but does not produce clinical dis-
ease in mice. Two experimental adaptations of SARS-
CoV to murine hosts by serial passage independently
identified a substitution in the Spike gene at residue
436 which alone has been shown to enhance infectivity
and pathogenesis in mice, and is predicted to allow
stronger binding to the murine ACE2 receptor
[29,57,58]. However, substitutions outside of Spike are
necessary for the full lethal disease phenotype in MA15,
and presumably also in v2163 [57]. For example, two
other proteins, nsp9 and nsp13, contained mutations in
both mouse-adapted strains, MA15 and v2163. Addition-
ally, single substitutions in the M gene are common to
MA15 and adaptation to persistent infection of human
tubular kidney cells, suggesting the M protein influences
tropism or pathogenesis by facilitating the efficiency of
particle egress [59]. The substitutions common to both
mouse-adapted strains suggest potential SARS-CoV viru-
lence factors in the later stages of adaption to a novel host,
and indicate potential mutation driven emergence path-
ways. The mouse-adapted viruses may not represent true
cross-species transmission events, as SARS could already
replicate in the mouse lung, but it is notable that the most
conserved change in both mouse-adapted strains
enhances receptor binding at the same Spike residue.
Further, serological studies indicate multiple cross-
species transmissions into humans in the years before
the epidemic, suggesting that the virulence factors con-
tributing to the later stages of adaptation to novel hosts, in
Spike or elsewhere, are critically important [23].
The RBD (aa318–510) is the strongest determinant of
host range for SARS-CoV and other coronaviruses [29].
Single substitutions within the RBD can significantly
affect the binding affinity of Spike to its receptor [60].
Indeed, a minimum of 1–2 substitutions in the RBD are
sufficient to allow the virus to alter host receptor speci-
ficity [61]. Experimental adaptation of civet-Spiked SAR-
S virus to human ACE2 receptor by Sheahan et al.
demonstrated the minimal requirements for host range
expansion. In these studies, a civet-Spiked SARS-CoV
was incapable of propagating in Vero cells until a human-
tropic substitution was introduced at residue 479. When
the civet-Spiked virus included the K479T substitution it
was capable of propagating on Vero cells and further
capable of replicating on human airway epithelial cells
(HAE) and hACE2-expressing DBT cells, demonstrating
that single substitutions are capable of expanding the
virus host range. Interestingly, when the K479T-civet-
SARS was experimentally selected for enhanced replica-
tion on human airway epithelial cells, the substitutions
that improved replication did not exactly replicate the
substitutions seen in the epidemic strains. Rather, an
initial substitution at 479 was necessary for the civet-
SARS to use primate ACE2 and propagate in Vero cells,
but the adaptive mutations following passage on human
airway epithelial cells (HAE) selected for substitutions at
two different contact interface sites at residues 442 and
472, rather than the 487 site identified in the epidemic
strain [61,62]. This suggests that multiple genetic path-
ways exist which can improve S RBD–human ACE2
receptor interactions, providing the virus with multiple
strategies to adapt to new host species [56]. It is inter-
esting to note that this alternative pathway for recogniz-
ing hACE2 ablated interactions with the cACE2 receptor,
supporting the hypothesis that epidemic SARS-CoV
strains were coselected to efficiently recognize both civet
and human ACE2 receptors.
Antibodies that neutralize SARS-CoV predominantly
bind to the RBD of Spike. Rockx et al. selected and
sequenced a number of different escape mutants to a
panel of 23 humanmonoclonal antibodies, themajority of
which contained single substitutions along the RBD
interface with ACE2 [63]. All but one escape site
mapped within 4 angstroms of contact interface residues,
and yet all viruses grew to comparable peak titers in Vero
and hACE2-restricted DBT cells. However, growth on
civet-ACE2-restricted DBT cells was restricted for all
escape viruses, suggesting that escape from antibody
neutralization can alter Spike–receptor binding and,
consequently, host range [63]. That antibody escapeFigure 3
SARS
ACE2ACE2
(a) (b)
Crystal structures of coronavirus receptor binding domains (RBDs) complexe
Spike RBD–receptor complexes have been solved: (a) the RBDs of SARS c
human ACE2 (3KBH) [71], and (c) MHV complexed with murine CEACAM1variants can stably adopt substitutions in the Spike–
ACE2 receptor interface suggests that the host response
to an infection may select for host range variants by a
mutation-driven mechanism.
Extensive structural modeling tools are available to pre-
dict receptor binding, antibody neutralization, or the
stability of substitutions within the RBD of the SCoV
Spike. Three coronavirus Spike-RBDs have been com-
plexed with receptors to date, allowing for prediction and
validation of the structural determinants of binding to
host and orthologous receptors (Figure 3). Application of
mathematical modeling to Spike–receptor and Spike–
antibody structural models allowed for the prediction
of escape substitutions with a high probability of fixation
in a viral population [64]. These predictions are partially
in accordance with published data, predicting selection
with antibody 80R would select for a substitution at D480
of Spike, as seen in vitro following SARS-CoV escape
from 80R neutralization [64,65].
Plasticity of the Spike glycoprotein
The coronavirus Spike glycoprotein is remarkably plastic,
capable of accommodating mutations and deletions up to
479 (MHV) or 681 nucleotides (PRCoV) while retaining
receptor binding and entry functions [66–68]. To date,
large deletions in the SARS-CoV S glycoprotein have not
been reported. The S protein is divided into discrete
domains: an N-terminal domain, RBD, two heptad
repeats, a transmembrane anchor, and an intracellular tailNL63 MHV
CEACAM1a
(c)
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d with their receptors. To date, the crystal structures of three coronavirus
omplexed with human ACE2 (pdb 2AJF) [73], (b) NL63 complexed with
1a (3R4D) [43].
[43]. Discrete regions can be exchanged between strains 
while preserving both protein function and antibody 
binding [29,36]. Multiple coincident substitutions as well 
as contact interface site substitutions can be tolerated to 
allow escape from antibody neutralization while main-
taining receptor specificity [42,60,69,70]. This flexibility 
allows for multiple genetic pathways from the use of 
zoonotic receptors to the human ACE2 receptor [56].
Diversity and flexibility of the Spike glycoprotein is charac-
teristic of coronaviruses beyond SARS-CoV. The lack of a 
clear ACE2 receptor binding motif (RBM) in the horseshoe 
Bat-SL-CoV Spike, and the inability to use hACE2 as a 
receptor, led to an early hypothesis that the human-SCoV 
emerged from Bat-SL-CoV following a recombination 
event, perhaps with a NL63-like CoV, as NL63 also uses 
ACE2 as a receptor. Such a recombination event would 
have allowed direct acquisition of an ACE2 binding motif 
and the resulting cross-species transmission [35]. Alterna-
tively, SARS-CoV used batACE2 for docking and entry 
and introduction into human/civet populations selected for 
mutations that enhanced interaction with the civet or 
humanACE2 receptor. The recently published crystal 
structure of NL63-CoV complexed with the ACE2 re-
ceptor shows no structural homology with the SARS-
CoV RBM or the core RBD (Figure 3) [71,72]. This 
suggests that convergent evolution, rather than recombi-
nation-mediated transfer, lead to the common use of ACE2 
by NL63 and SARS-CoV [72].
Early data suggested that the RBD of SARS-CoV and 
perhaps HCoV-NL63 were derived by recombination 
processes, rather than mutation driven evolution. While 
these ideas remain highly speculative, these data 
suggested that the S glycoprotein RBDs and/or fusion 
cores of CoVs may be interchangeable between distant 
strains. In support of this hypothesis, the consensus bat 
SARS-like genome HKU3 was replication competent, but 
was not sufficient for sequential rounds of infection, 
presumably because of the lack of appropriate receptors 
for docking and entry. The insertion of the SARS RBD 
into the HKU3 Spike allowed for the production of 
progeny virus that grew to high titer in ACE2-expressing 
DBT cells, and was capable of replicating in human 
airway epithelial cells and mouse lungs, although it grew 
with reduced efficiency in the latter [29]. Thus, under 
certain conditions, recombination processes can result in 
bat CoV host shifting. Further, the bat-SARS-like coro-
navirus with the SARS RBD was capable of replicating in 
mouse lungs, although with greatly reduced efficiency. It 
is notable that attempts to isolate CoV from bats have 
repeatedly failed, limiting our ability to study adaptive 
mechanisms or pathogenesis of CoV in host species, but 
that synthetic biology provides alternative sources of 
these viruses. The construction of a synthetic bat SAR-
S-like coronavirus provided strong evidence that the 
interspecies movement of coronaviruses, specificallySARS-like coronaviruses, resides strongly in the RBD
[29]. While previous studies had indicated that small
changes in the Spike glycoprotein could alter host speci-
ficity of coronaviruses, the sufficiency of a discrete RBD
change in the context of a divergent 30 kb genome
demonstrates the RBD is a minimum determinant of
species tropism. Further, it suggests a potential mechan-
ism of host range expansion, suggesting both recombina-
tion and single substitution events allow for infection of
novel hosts. Determining receptor specificities for these
novel bat coronaviruses offer considerable opportunity to
enrich our understanding of coronavirus–receptor inter-
actions, identify new receptors that coronaviruses use for
docking and entry, and provide novel models for studying
the ease and mechanism of cross-species transmission.
Conclusions
Fundamental insights into the molecular mechanisms
and pathways that govern virus cross-species transmission
are central to protecting global health. Coronaviruses
readily traffic between host species and the Spike glyco-
protein is the most extensively characterized viral deter-
minant of host range expansion. Binding of the
coronavirus Spike to the host receptor is the minimum
determinant of infectivity and species specificity, and
many recent studies have demonstrated the ability of S
RBD to mutate and engage ortholog receptors or escape
antibody neutralization [61,63]. We need to know more
about the breath of novel coronavirus receptors that are
used in nature and the mechanisms governing ortholog
receptor recognition. Importantly, the coronavirus RBD
interface is a robust iterative model for predicting struc-
ture–function relationships between mutation-driven
host range expansion, virus–receptor interactions, and
antibody binding and neutralization. The SARS S-RBD
model captures highly regulated variables that recapitu-
late real-life biological processes critical for coronavirus
cross-species transmission and host immune response
(Figure 4). The SARS RBD–receptor–neutralizing anti-
body interface provides considerable opportunity for pre-
dicting and studying the role of mutations in cross-species
transmission and immunity. In addition, recent work has
also expanded our appreciation of how intragenic recom-
bination may influence coronavirus host range, as evi-
denced by targeted recombination, recombination
between different bat coronaviruses, and identification
of the RBD as a minimum determinant of host range
expansion [29,39]. While the precise ancestor and route
of emergence for SARS-CoV remains unidentified, exten-
sive sampling and phylogenetic studies of bat CoVs has
raised the possibility that the epidemic strain may have
jumped directly to humans before jumping to civets.
Thus, future coronavirus epidemics may be more fre-
quent than appreciated as compared with a two-step
emergence model that required an intermediate host.
Additionally, while it remains unclear whether recombi-
nation and/or mutation of Spike mediated the emergence
Figure 4
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Experimental evolution at the SARS S glycoprotein RBD–ligand interface. The SARS RBD is heterogeneous and includes defined sequence variation at
specific residues that engage the ACE2 receptor from different species (Parts 1 and 2). Bioinformatics can be used to predict and then test the impact
of targeted mutations on variant virus–receptor interactions. Iterative rounds of mutation driven selection are also possible using recombinant viruses
encoding targeted mutations and variant ACE2 receptors for docking and entry. The model allows a deep structural understanding of the potential
pathways and molecular mechanisms that govern cross-species transmission and pathogenesis. The biological impact of host shifting on antigenicity
can be predicted using structural models of antibody–RBD interfaces, and then studied using a panel of well characterized human and mouse
monoclonal antibodies targeting the different SARS-CoV RBD domains (Part 3). In parallel, neutralizing monoclonal antibodies can be used to select for
escape mutations (Part 4), allowing for iterative rounds of prediction and testing on how these mutations impact host range and ACE2 recognition.of SARS, both mechanisms can readily impact corona-
virus host range. Future studies are needed to clarify the
potential roles of host proteases or antibody mediated
selection in cross-species transmission, and to clarify
whether modulation of RNA proof-reading activity could
impact viral adaptation to a novel host. Further, structural
and mathematical modeling tools offer novel predictive
capabilities that, when integrated with experimental stu-
dies, will assist in predicting the ease of cross-species
transmission, the mechanisms of emergence, and contrib-
ute to improvements in therapeutic design.
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